MedTrace Logo

Direct Transfer to an Endovascular Center Compared to Transfer to the Closest Stroke Center in Acute Stroke Patients With Suspected Large Vessel Occlusion

NCT02795962 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1401

Last updated 2021-03-16

No results posted yet for this study

Summary

To evaluate the hypothesis that direct transfer to an Endovascular Stroke Center, compared to transfer to the closest Local Stroke Center, offers a better outcome in the distribution of the modified Rankin Scale scores at 90 days in acute ischemic stroke patients with clinically suspected Large Vessel Occlusion identified by Emergency Medical Services (EMS).

Conditions

Interventions

OTHER

Direct transfer to an Endovascular Center

Cluster randomized controlled study: allocation to active or no intervention arm will be performed accordingly to a pre-established temporal sequence

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Anagram-ESIC

    collaborator UNKNOWN

  • UPC

    collaborator UNKNOWN

  • BioClever 2005 S.L.

    collaborator OTHER

  • Fundacio Ictus Malaltia Vascular

    lead OTHER

Principal Investigators

  • Marc Ribó, PhD · Hospital Universitari Vall d'Hebrón, Barcelona, Spain

  • Sonia Abilleira, PhD · Pla Director Malaltia Vascular Cerebral. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)

  • Natalia Pérez de la Ossa, PhD · Hospital Universitari Germans Trias i Pujol, Badalona, Spain

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02795962 on ClinicalTrials.gov